Domov › Poklici › Bioengineers and Biomedical Engineers › Seattle, WA
Bioengineers and Biomedical Engineers v Seattle, WA: plače H-1B
24 vlog za delovne pogoje za ta poklic z delovnim mestom v Seattle, WA. Medianna osnovna plača $84.431; srednja polovica $74.250–$120.968.
Po plačilnem razredu
| Raven plače | Mediana plače |
|---|---|
| Stopnja I (začetna) | $78.226 |
| Stopnja II (kvalificirana) | $87.861 |
| Stopnja III (izkušena) | $125.000 |
| Stopnja IV (polno usposobljena) | $170.000 |
Department of Labor določi štiri stopnje prevladujočih plač za vsak poklic in območje, od Stopnje I (začetna) do Stopnje IV (popolna usposobljenost). Delodajalec izbere stopnjo, ki ustreza zahtevam delovnega mesta.
Delodajalci
| Delodajalec | LCA | Mediana plače |
|---|---|---|
| University of Washington | 8 | $71.706 |
| Allen Institute | 3 | $82.742 |
| Keyamed Na Inc | 2 | $120.968 |
| Seattle Children's Hospital | 2 | $75.000 |
| Concord III, LLC | 1 | $222.000 |
| Devote Consulting Inc. | 1 | $170.000 |
| Novo Nordisk Research Center Seattle Inc. | 1 | $81.453 |
| Cartography Biosciences, Inc. | 1 | $130.000 |
| Food and Drug Administration | 1 | $109.546 |
| Key Proteo, Inc. | 1 | $95.722 |
| Becton, Dickinson and Company | 1 | $125.000 |
| InBios International, Inc. | 1 | $75.000 |
| Bristol-Myers Squibb Company | 1 | $294.662 |
Nazivi delovnih mest
- Postdoctoral Scholar6
- Senior Imaging Engineer2
- Invent Fellow - PhD, Research2
- Scientist I2
- Scientific Data Engineer1
- Senior Product Manager1
- Senior Consultant1
- Engineer II1
- Data Scientist1
- Visiting Associate1
- Research Scientist1
- Sr. Quality Engineer1
- Research Scientist/Engineer 41
- Research Scientist/Engineer 21
- Quality Engineer I1
Sponzorji H-1B v Seattle, WA →
Plače so spodnja meja ponujene plače pri vsaki vlogi, pretvorjene v letni znesek; statistika uporablja samo potrjene vloge za polni delovni čas. LCA ni odobritev vizuma, ena LCA pa lahko pokriva več delovnih mest. Vir: U.S. Department of Labor, OFLC LCA Disclosure Data, davčna leta 2023–2026 (najnovejša odločitev 30. jun. 2026).